Ubs Group Ag Xtant Medical Holdings, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1 shares of XTNT stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.35 - $0.66 $13,666 - $25,771	-39,047 Reduced 100.0%	1 $0
Q3 2024 Nov 14, 2024	BUY	$0.55 - $0.8 $17,181 - $24,991	31,239 Added 400.04%	39,048 $26,000
Q2 2024 Aug 13, 2024	SELL	$0.63 - $1.03 $399 - $653	-634 Reduced 7.51%	7,809 $4,000
Q1 2024 May 13, 2024	BUY	$0.92 - $1.28 $7,682 - $10,689	8,351 Added 9077.17%	8,443 $9,000
Q4 2023 Feb 09, 2024	SELL	$1.04 - $1.39 $4,292 - $5,736	-4,127 Reduced 97.82%	92 $0
Q3 2023 Nov 09, 2023	BUY	$0.78 - $1.35 $3,290 - $5,695	4,219 New	4,219 $4,000
Q1 2023 May 12, 2023	BUY	$0.59 - $1.18 $3,370 - $6,740	5,712 Added 422.8%	7,063 $4,000
Q4 2022 Feb 08, 2023	BUY	$0.5 - $0.8 $675 - $1,080	1,351 New	1,351 $0
Q2 2022 Aug 10, 2022	BUY	$0.47 - $0.7 $2,297 - $3,421	4,888 New	4,888 $3,000
Q1 2022 May 16, 2022	SELL	$0.57 - $0.88 $25,490 - $39,353	-44,720 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.26 $25,043 - $56,347	44,720 New	44,720 $25,000
Q1 2021 May 12, 2021	SELL	$1.23 - $4.33 $1,552 - $5,464	-1,262 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$0.82 - $1.63 $1,034 - $2,057	1,262 New	1,262 $2,000
Q3 2020 Nov 12, 2020	SELL	$0.76 - $1.6 $892 - $1,878	-1,174 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$0.62 - $1.74 $6,146 - $17,250	-9,914 Reduced 89.41%	1,174 $1,000
Q1 2020 May 01, 2020	BUY	$0.63 - $1.64 $6,985 - $18,184	11,088 New	11,088 $7,000
Q1 2019 May 14, 2019	SELL	$2.09 - $4.45 $3,943 - $8,397	-1,887 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $4.0 $1,865 - $4,636	1,159 Added 159.2%	1,887 $3,000
Q3 2018 Nov 14, 2018	SELL	$3.85 - $6.2 $29,737 - $47,888	-7,724 Reduced 91.39%	728 $3,000
Q2 2018 Aug 14, 2018	BUY	$5.33 - $8.31 $24,576 - $38,317	4,611 Added 120.05%	8,452 $47,000
Q1 2018 May 15, 2018	BUY	$4.56 - $9.75 $17,514 - $37,449	3,841 New	3,841 $30,000

Others Institutions Holding XTNT

# of Institutions

Shares Held

79.9M

Call Options Held

Put Options Held

Nantahala Capital Management, LLC New Canaan, CT

68.4M
Shares

$45.8 Million
2.21% of portfolio
Awm Investment Company, Inc. New York, NY

6.6M
Shares

$4.42 Million
0.7% of portfolio
Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$1.51 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

651K
Shares

$435,975
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

554K
Shares

$370,928
0.0% of portfolio

View Full List

About Xtant Medical Holdings, Inc.

Ticker XTNT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 108,226,000
Market Cap $72.5M
Description
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...

More about XTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account